NCT06131385Recruiting
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China（IVTIS）
Source: ClinicalTrials.gov · Last updated 28 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 9 Nov 2023
- Start date
- 20 Nov 2023
- Primary completion date
- 15 Dec 2045
- Lead sponsor
- Zhengzhou Yuan
- Diseases
- Stroke
- NCT number
- NCT06131385
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 20 Nov 2023 to the primary completion date, 15 Dec 2045
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No additional exclusion criteria.
Who the study is looking for
- The patient was diagnosed with acute ischemic stroke and received intravenous thrombolysis.
Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Affiliated Hospital of Southwest Medical University Coordinator of this site? Confirm its status | Luzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.